Heyuan biology: the winning rate is 0.03616551%
Heyuan biology announced that after the callback mechanism was started, the final winning rate of online issuance was 0.03616551%.
This text is a result of machine translation.
Related companies：
Briefing May 11, 2022 01:15 PM
· Technology
Photovoltaic sector continues to be active
Briefing May 10, 2022 06:30 PM
· Technology
Boschke: the consortium pre won the 168 million yuan EPC project
In-depth
Healthcare
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Briefing Apr 28, 2022 08:55 AM
CITIC Securities: the auction price of lithium concentrate rose sharply, and the lithium plate rebounded or advanced
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Mar 10, 2022 12:48 PM
· Consumer Staples
Half day net inflow of main funds into photovoltaic and lithium batteries, selling small metals, etc
See more
Read next
Insight
In-depth
Consumer Discretionary · Analysis
Black Friday Kicks Off: How to Navigate the Latin American Market?
Yesterday 10:36 AM
Insight
In-depth
Consumer Staples, Consumer Discretionary · Interview
Exploring Uncharted Territories in the Middle East: The Innovators Going Global
Nov 19, 2024 03:20 PM
Insight
In-depth
Insight
In-depth
Consumer Staples
The Billion-Dollar European Caviar Business, Now Disrupted by China
Nov 08, 2024 01:52 PM